3D bioprinting of stem cells and polymer/bioactive glass composite scaffolds for bone tissue engineering

© Invalid date by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )

Download PDF

Cite

XML

Abstract

A major limitation of using synthetic scaffolds in tissue engineering applications is insufficient angiogenesis in scaffold interior. Bioactive borate glasses have been shown to promote angiogenesis. There is a need to investigate the biofabrication of polymer composites by incorporating borate glass to increase the angiogenic capacity of the fabricated scaffolds. In this study, we investigated the bioprinting of human adipose stem cells (ASCs) with a polycaprolactone (PCL)/bioactive borate glass composite. Borate glass at the concentration of 10 to 50 weight %, was added to a mixture of PCL and organic solvent to make an extrudable paste. ASCs suspended in Matrigel were ejected as droplets using a second syringe. Scaffolds measuring 10 × 10 × 1 mm3 in overall dimensions with pore sizes ranging from 100 – 300 µm were fabricated. Degradation of the scaffolds in cell culture medium showed a controlled release of bioactive glass for up to two weeks. The viability of ASCs printed on the scaffold was investigated during the same time period. This 3D bioprinting method shows a high potential to create a bioactive, highly angiogenic three-dimensional environment required for complex and dynamic interactions that govern the cell’s behavior in vivo.

Keywords

Eioprinting

biofabrication

human adipose-derived stem cell

MSCs

bioactive glass

polycaprolactone

scaffold

tissue engineering

References

1. Zhang P, Zhang X, Brown J B, et al., 2010, Economic impact of diabetes. IDF Diabetes Atlas.
2. Banwart J C, Asher M A and Hassanein R S, 1995, Iliac crest bone graft harvest donor site morbidity. A statistical evaluation. Spine (Phila. Pa. 1976), vol.20(9): 1055–1060.
https://doi.org/10.1097/00007632-199505000-00012.
3. Goulet J A, Senunas L E, DeSilva G L, et al., 1997, Autogenous iliac crest bone graft. Complications and functional assessment. Clinical Orthophopedics and Related Research, (339): 76–81.
https://doi.org/10.1097/00003086-199706000-00011
4. Giannoudis P V, Dinopoulos H and Tsiridis E, 2005, Bone substitutes: An update. Injury, vol.36(3): S20–S27.
http://dx.doi.org/10.1016/j.injury.2005.07.029.
5. Doiphode N D, Huang T, Leu M C, et al., 2011, Freeze extrusion fabrication of 13–93 bioactive glass scaffolds for bone repair. Journal of Materials Science: Materials in Medicine, vol.22(3): 515–523.
http://dx.doi.org/10.1007/s10856-011-4236-4.
6. Kolan K C R, Leu M C, Hilmas G E, et al., 2012, Effect of material, process parameters, and simulated body fluids on mechanical properties of 13–93 bioactive glass porous constructs made by selective laser sintering. Journal of Mechanical Behaviour of Biomedical Materials, vol.13: 14–24.
http://dx.doi.org/10.1016/j.jmbbm.2012.04.001.
7. Bartolo P, Kruth J P, Silva J, et al., 2012, Biomedical production of implants by additive electrochemical and physical processes. CIRP Annals — Manufacturing Technology, vol.61(2): 635–655.
http://dx.doi.org/10.1016/j.cirp.2012.05.005.
8. Temple J P, Hutton D L, Hung B P, et al., 2014, Engineering anatomically shaped vascularized bone grafts with hASCs and 3D-printed PCL scaffolds. Journal of Biomedical Materials Research Part A, vol.102(12): 4317–4325.
http://dx.doi.org/10.1002/jbm.a.35107.
9. Rahaman M N, Day D E, Sonny Bal B, et al., 2011, Bioactive glass in tissue engineering. Acta Biomaterialia, vol.7(6): 2355–2373.
http://dx.doi.org/10.1016/j.actbio.2011.03.016.
10. Liu X and Ma P X, 2004, Polymeric scaffolds for bone tissue engineering. Annals Biomedical Engineering, vol.32(3): 477–486.
http://dx.doi.org/10.1023/B:ABME.0000017544.36001.8e.
11. Bose S, Vahabzadeh S and Bandyopadhyay A, 2013, Bone tissue engineering using 3D printing. Materials Today, vol.16(12): 496–504.
http://dx.doi.org/10.1016/j.mattod.2013.11.017.
12. Puska M, Aha A J and Vallittu P, 2011, Polymer composites for bone reconstruction. Advances in Composite Materials – Analysis of Natural Man-Made Materials, http://dx.doi.org/10.5772/20657.
13. Rezwan K, Chen Q Z, Blaker J J, et al., 2006, Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biom-aterials, vol.27(18): 3413–3431.
http://dx.doi.org/10.1016/j.biomaterials.2006.01.039.
14. Guillotin B, Souquet A, Catros S, et al., 2010, Laser assisted bioprinting of engineered tissue with high cell density and microscale organization. Biomaterials, vol.31(28): 7250–7256.
http://dx.doi.org/10.1016/j.biomaterials.2010.05.055.
15. Yan J, Huang Y, Chrisey D B, et al., 2013, Laser-assisted printing of alginate long tubes and annular constructs. Biofabrication, vol.5(1): 15002.
http://dx.doi.org/10.1088/1758-5082/5/1/015002.
16. Chang C C, Boland E D, Williams S K, et al., 2011, Direct-write bioprinting three-dimensional biohybrid systems for future regenerative therapies. Journal of Biomedical Materials Research Part B: Applied Biomaterials, vol.98B(1): 160–170.
http://dx.doi.org/10.1002/jbm.b.31831.
17. Ozbolat I T and Hospodiuk M, 2016, Current advances and future perspectives in extrusion-based bioprinting. Biomaterials, vol.76:321–343.
http://dx.doi.org/10.1016/j.biomaterials.2015.10.076
18. Murphy S V and Atala A, 2014, 3D bioprinting of tissues and organs. Nature Biotechnology, vol.32(8): 773–785.
http://dx.doi.org/10.1038/nbt.2958
19. Kang H-W, Lee S J, Ko I K, et al., 2015, A 3D bioprinted complex structure for engineering the muscle–tendon unit. Biofabrication, vol.7(3): 35003.
http://dx.doi.org/10.1088/1758-5090/7/3/035003.
20. Wu Z, Su X, Xu Y, et al., 2016, Bioprinting three-dimensional cell-laden tissue constructs with controllable degradation. Science Reports, vol.6: 24474.
http://dx.doi.org/10.1038/srep24474.
21. Lin Y, Brown R F, Jung S B, et al., 2014, Angiogenic effects of borate glass microfibers in a rodent model. Journal of Biomedical Materials Research Part A, vol.102(12): 4491–4499.
http://dx.doi.org/10.1002/jbm.a.35120.
22. Jung S B and Day D E, 2011, Revolution in wound care? Inexpensive, easy-to-use cotton candy-like glass fibers appear to speed healing in initial venous stasis wound trial. The American Ceramic Society Bulletin, vol.90(4): 25–29.
23. Salem H K and Thiemermann C, 2009, Mesenchymal stromal cells: current understanding and clinical status. Stem Cells, vol.28(3): 585–596.
http://dx.doi.org/10.1002/stem.269.
24. Wu Y, Chen L, Scott P G, et al., 2007, Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells, vol.25(10): 2648–2659.
http://dx.doi.org/10.1634/stemcells.2007-0226.
25. De Ugarte D A, Morizono K, Elbarbary A, et al., 2003, Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs, vol.174(3): 101–109.
http://dx.doi.org/10.1159/000071150.
26. Izadpanah R, Trygg C, Patel B, et al., 2006, Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue. Journal of Cellular Biochemistry, vol.99(5): 1285–1297.
http://dx.doi.org/10.1002/jcb.20904.
27. Wagner W, Wein F, Seckinger A, et al., 2005, Comp¬arative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical co-rd blood. Experimental Hematology, vol.33(11): 1402– 1416.
http://dx.doi.org/10.1016/j.exphem.2005.07.003.
28. Sakaguchi Y, Sekiya I, Yagishita K, et al., 2005, Comparison of human stem cells derived from various mesenchymal tissues: Superiority of synovium as a cell source. Arthritis Rheumatology, vol.52(8): 2521–2529.
http://dx.doi.org/10.1002/art.21212.
29. D’Andrea F, De Francesco F, Ferraro G A, et al., 2008, Large-scale production of human adipose tissue from stem cells: A new tool for regenerative medicine and tissue banking. Tissue Engineering Part C Methods, vol.14(3): 233–242.
http://dx.doi.org/10.1089/ten.tec.2008.0108
30. Casteilla L and Dani C, 2006, Adipose tissue-derived cells: from physiology to regenerative medicine. Diabetes & Metabolism, vol.32(5 Pt 1): 393–401.
http://dx.doi.org/DM-11-2006-32-5-1262-3636-101019-200519820.
31. Lee J T Y, Leng Y, Chow K L, et al., 2011, Cell culture medium as an alternative to conventional simulated body fluid. Acta Biomaterialia vol.7(6): 2615–2622
http://dx.doi.org/10.1016/j.actbio.2011.02.034.
32. Miller-Chou B A and Koenig J L, 2003, A review of polymer dissolution. Progress in Polymer Science, vol.28(8): 1223–1270.
http://dx.doi.org/10.1016/S0079-6700(03)00045-5.
33. Woodruff M A and Hutmacher D W, 2010, The return of a forgotten polymer — polycaprolactone in the 21st century. Progress in Polymer Science, vol.35(10): 1217– 1256.
http://dx.doi.org/10.1016/j.progpolymsci.2010.04.002.
34. Korpela J, Kokkari A, Korhonen H, et al., 2013, Biodegradable and bioactive porous scaffold structures prepared using fused deposition modeling. Journal of Biomedical Materials Research Part B: Applied Biomaterials, vol.101B(4): 610–619.
http://dx.doi.org/10.1002/jbm.b.32863.
35. Mohammadkhah A, Marquardt L M, Sakiyama-Elbert S E, et al., 2015, Fabrication and characterization of poly-(ε)-caprolactone and bioactive glass composites for tissue engineering applications. Materials Science and Engineering: C, vol.49: 632–639.
http://dx.doi.org/10.1016/j.msec.2015.01.06.

Previous article in this issue

Next article in this issue

International Journal of Bioprinting, Electronic ISSN: 2424-8002 Print ISSN: 2424-7723, Published by AccScience Publishing